KAKZF yields 6.67% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 6
Combined, KAKZF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KAKZF + JNJ for your $10,000?
Joint Stock Company Kaspi.kz, together with its subsidiaries, provides financial services primarily through the online mobile app in the Republic of Kazakhstan. The company operates through three segments: Payments Platform, Marketplace Platform, and Fintech Platform. The Payments Platform segment connects its customers comprising consumer and merchants to facilitate cashless and digital payment transactions. This segment also offers a technology platform to pay and receive payments for goods and services, as well as to transfer and withdraw money. The Marketplace Platform segment connects merchants and consumers enabling merchants to enhance its sales and enable consumers to buy a selection of products and services from various merchants. The Fintech Platform segment enables its consumers to manage its personal finances online and access consumer finance and deposit products primarily through the Kaspi.kz Super App. It is also involved in the e-commerce, banking, insurance, and asset management services; real estate business; and provision of online travel and payment processing services. The company was incorporated in 2008 and is based in Almaty, the Republic of Kazakhstan.
Full KAKZF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.